Snapshot from Jul 04, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / United States — Food and Drug Administration / Revolution Medicines

United States — Food and Drug Administration & Revolution Medicines

1 shared events · Importance 3 · Last updated Jun 04, 2026

Importance
3
Shared Events
1
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (1)
20
International
US-Iran Strait of Hormuz Conflict
United States — Food and Drug Administration: The United States — Food and Drug Administration is the regulatory body that Revolution Medicines will seek approval from for its experimental pancreatic cancer drug, daraxonrasib.
Revolution Medicines: Revolution Medicines is the maker of daraxonrasib, an experimental pill showing promise for advanced pancreatic cancer, and plans to seek United States — Food and Drug Administration approval.
May 18, 2026 · 316 articles
NEWSDESK
Explore this relationship live

Track how United States — Food and Drug Administration and Revolution Medicines interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.